» Articles » PMID: 32362838

Quantitative Modeling Extends the Antibacterial Activity of Nitric Oxide

Overview
Journal Front Physiol
Date 2020 May 5
PMID 32362838
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Numerous materials have been developed to try and harness the antimicrobial properties of nitric oxide (NO). However, the short half-life and reactivity of NO have made precise, tunable delivery difficult. As such, conventional methodologies have generally relied on donors that spontaneously release NO at different rates, and delivery profiles have largely been constrained to decaying dynamics. In recent years, the possibility of finely controlling NO release, for instance with light, has become achievable and this raises the question of how delivery dynamics influence therapeutic potential. Here we investigated this relationship using as a model organism and an approach that incorporated both experimentation and mathematical modeling. We found that the best performing delivery mode was dependent on the NO payload, and developed a mathematical model to quantitatively dissect those observations. Those analyses suggested that the duration of respiratory inhibition was a major determinant of NO-induced growth inhibition. Inspired by this, we constructed a delivery schedule that leveraged that insight to extend the antimicrobial activity of NO far beyond what was achievable by traditional delivery dynamics. Collectively, these data and analyses suggest that the delivery dynamics of NO have a considerable impact on its ability to achieve and maintain bacteriostasis.

Citing Articles

Role of the multiple efflux pump protein TolC on growth, morphology, and biofilm formation under nitric oxide stress in .

Liu D, Wang Y, Wang X, Ou D, Ling N, Zhang J JDS Commun. 2022; 2(3):98-103.

PMID: 36339506 PMC: 9623651. DOI: 10.3168/jdsc.2020-0040.


NO donors and NO delivery methods for controlling biofilms in chronic lung infections.

Cai Y, Zhang Y, Yang L Appl Microbiol Biotechnol. 2021; 105(10):3931-3954.

PMID: 33937932 PMC: 8140970. DOI: 10.1007/s00253-021-11274-2.


Pseudomonas aeruginosa prioritizes detoxification of hydrogen peroxide over nitric oxide.

Sivaloganathan D, Brynildsen M BMC Res Notes. 2021; 14(1):120.

PMID: 33771209 PMC: 7995768. DOI: 10.1186/s13104-021-05534-7.


Antimicrobial properties of diethylamine NONOate, a nitric oxide donor, against Escherichia coli: a pilot study.

Sysel A, Dunphy M, Bauer J J Antibiot (Tokyo). 2020; 74(4):260-265.

PMID: 33361779 PMC: 7767638. DOI: 10.1038/s41429-020-00397-9.

References
1.
MacMicking J, Nathan C, Hom G, Chartrain N, Fletcher D, Trumbauer M . Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 1995; 81(4):641-50. DOI: 10.1016/0092-8674(95)90085-3. View

2.
Henard C, Vazquez-Torres A . Nitric oxide and salmonella pathogenesis. Front Microbiol. 2011; 2:84. PMC: 3153045. DOI: 10.3389/fmicb.2011.00084. View

3.
Brynildsen M, Winkler J, Spina C, MacDonald I, Collins J . Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production. Nat Biotechnol. 2013; 31(2):160-5. PMC: 3568245. DOI: 10.1038/nbt.2458. View

4.
Robinson J, Brynildsen M . A kinetic platform to determine the fate of nitric oxide in Escherichia coli. PLoS Comput Biol. 2013; 9(5):e1003049. PMC: 3642044. DOI: 10.1371/journal.pcbi.1003049. View

5.
Mehta H, Liu Y, Zhang M, Spiro S . Genome-wide analysis of the response to nitric oxide in uropathogenic CFT073. Microb Genom. 2017; 1(4):e000031. PMC: 5320621. DOI: 10.1099/mgen.0.000031. View